Working at NewLink Genetics | Glassdoor

NewLink Genetics Overview

Ames, IA
51 to 200 employees
Company - Public (NLNK)
Biotech & Pharmaceuticals
$100 to $500 million (USD) per year
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer.

With more than 15 years of experience researching and developing exciting new ... Read more

Mission: Our mission is to fundamentally change the way cancer is treated to improve the lives of patients.

NewLink Genetics Reviews

Star Star Star Star Star
Rating Trends Rating Trends
Recommend to a friend
Approve of CEO
(no image)
Dr. Charles J. Link
8 Ratings
  • "Growing BioTech"

    Star Star Star Star Star
    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Current Employee in Ames, IA
    Current Employee - Current Employee in Ames, IA
    Positive Outlook
    Approves of CEO

    I have been working at NewLink Genetics full-time


    HR (Maggi, Ronee, etc) is amazing, great co-workers, and great benefits.

    It is a fast paced environment with amazing, caring, and passionate management. I saw some comments about upper management not being available, but they are traveling on behalf of the company (investor meetings, healthcare conferences, etc etc etc) a majority of the time. When they are in the office they always have an open door policy.

    My coworkers are all wonderful, kind, and talented. Everyone pushes themselves to be the best they can be for a company who gives so much back. This company has never lost sight of its main goal: helping people.



    I have been a part of the NewLink team for several years now and I still don't have anything negative to say.

See All 16 Reviews

Company Updates



    Ebola vaccine's triumph will lead to reward for Ames company

    An Iowa vaccine company is basking in the news that a product it helped develop can stop one of the world's deadliest viruses. A study published Thursday showed that the vaccine is 100 percent effective in protecting people from Ebola, an extremely infectious virus that has killed thousands and terrorized millions, mainly in Africa.

See All See All

NewLink Genetics Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add Awards

Work at NewLink Genetics? Share Your Experiences

NewLink Genetics
  • Star
  • Star
  • Star
  • Star
  • Star
Click to Rate